Skip to main content

Cervical Cancer

  • Chapter

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Cervical cancer is a malignancy occurring worldwide. In developing countries, cervical cancer can be epidemic and is higher in incidence and prevalence than in this country due to Pap smear screening. If the disease process is found early, many patients can be diagnosed with CIN and be treated without ever developing invasive cancer. As the disease progresses to invasive cancer, even advanced stages can be treated and cured.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Benedet JL, Bender H, Jones H 3rd et al. (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262

    Article  PubMed  CAS  Google Scholar 

  • Burghardt E, Pickel H (1978) Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52:138–145

    PubMed  CAS  Google Scholar 

  • Bush R (1986) The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 12:2047–2050

    PubMed  CAS  Google Scholar 

  • Delgado G, Bundy BN, Fowler WC Jr et al (1989) A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 35:314–320

    Article  PubMed  CAS  Google Scholar 

  • Eifel PJ, Winter K, Morris M et al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and paraaortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22:872–880

    Article  PubMed  Google Scholar 

  • Finlay MH, Ackerman I, Tirona RG et al (2006) Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks. Int J Radiat Oncol Biol Phys 64:205–209

    PubMed  Google Scholar 

  • Fyles A, Keane TJ, Barton M et al (1992) The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 25:273–279

    Article  PubMed  CAS  Google Scholar 

  • Girinski T, Pejovic-Lenfant MH, Bourhis J et al (1989) Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 16:37–42

    PubMed  CAS  Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F et al (2003) Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 55:907–913

    PubMed  Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F et al (2004) Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22:2167–2171

    Article  PubMed  Google Scholar 

  • Grogan M, Thomas GM, Melamed I et al (1999) The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86:1528–1536

    Article  PubMed  CAS  Google Scholar 

  • Herbst AL, Cole P, Norusis MJ et al (1979) Epidemiologic aspects and factors related to survival in 384 registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 135:876–886

    PubMed  CAS  Google Scholar 

  • International Commission of Radiation Units and Measurements (1985) Dose and volume specifications for reporting intracavitary therapy in gynecology. ICRU Report 38. International Commission on Radiation Units, Bethesda, MD

    Google Scholar 

  • Kapp KS, Poschauko J, Geyer E et al (2002) Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 54:58–66

    PubMed  Google Scholar 

  • Keys HM, Bundy BN, Stehman FB et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161

    Article  PubMed  CAS  Google Scholar 

  • Kolstad P (1989) Follow-up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 33:265–272

    Article  PubMed  CAS  Google Scholar 

  • Lanciano RM, Martz K, Coia LR et al (1993) Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys 20:95–100

    Google Scholar 

  • Landoni F, Maneo A, Colombo A et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350:535–540

    Article  PubMed  CAS  Google Scholar 

  • Loft A, Berthelsen AK, Roed H et al (2007) The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106:29–34

    Article  PubMed  Google Scholar 

  • Look KY, Brunetto VL, Clarke-Pearson DL et al (1996) An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 63:304–311

    Article  PubMed  CAS  Google Scholar 

  • Monk BJ, Wang J, Im S et al (2005) Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 96:721–728

    Article  PubMed  Google Scholar 

  • Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143

    Article  PubMed  CAS  Google Scholar 

  • Mundt AJ, Lujan AE, Rotmensch J et al (2002) Intensitymodulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330–1337

    Article  PubMed  Google Scholar 

  • Nag S, Erickson B, Thomadsen B et al (2000) The American Brachytherapy Society recommendations for high-doserate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48:201–211

    Article  PubMed  CAS  Google Scholar 

  • National Comprehensive Cancer Network (2007) Clinical practice guidelines in oncology: Cervical vancer, version 1.2008. Available at http://www.nccn.org/professionals/physician_gls/PDF/cervical.pdf. Last accessed on 8 March 2008

    Google Scholar 

  • Patel FD, Sharma SC, Negi PS et al (1994) Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 28:335–341

    PubMed  CAS  Google Scholar 

  • Perez CA, Camel HM, Kuske RR et al (1986) Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol 23:127–140

    Article  PubMed  CAS  Google Scholar 

  • Perez CA, Grigsby PW, Castro-Vita H et al (1995) Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 32:1275–1288

    PubMed  CAS  Google Scholar 

  • Peters WA, Liu PY, Barrett RJ et al (2000) Concurrent chemotherapy and pelvic radiation therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613

    PubMed  CAS  Google Scholar 

  • Petereit DG, Sarkaria JN, Chappell R et al (1995) The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1301–1307

    PubMed  CAS  Google Scholar 

  • Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153

    Article  PubMed  CAS  Google Scholar 

  • Sedlis A, Bundy BN, Rotman MZ et al (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 73:177–183

    Article  PubMed  CAS  Google Scholar 

  • Sethi TK, Bhalla NK, Jena AN et al (2005) Magnetic resonance imaging in carcinoma cervix-does it have a prognostic relevance. J Cancer Res Ther 1:103–107

    Article  PubMed  Google Scholar 

  • Shingleton HM, Bell MC, Fremgen A et al (1995) Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 76(10 Suppl):1948–1955

    Article  PubMed  CAS  Google Scholar 

  • Sironi S, Buda A, Picchio M et al (2006) Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238:272–279

    Article  PubMed  Google Scholar 

  • Stehman FB, Bundy BN, DiSaia PJ et al (1991) Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776–2785

    Article  PubMed  CAS  Google Scholar 

  • Stehman FB, Ali S, Keys HM et al (2007) Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 197:503. e1–6

    Article  PubMed  CAS  Google Scholar 

  • Takeda N, Sakuragi N, Takeda M et al (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81:1144–1151

    Article  PubMed  Google Scholar 

  • Teshima T, Inoue T, Ikeda H et al (1993) High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital. Cancer 72:2409–2414

    Article  PubMed  CAS  Google Scholar 

  • Wagenaar HC, Trimbos JB, Postema S et al (2001) Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 82:474–482

    Article  PubMed  CAS  Google Scholar 

  • Whitney CW, Sause W, Bundy BN et al (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIBIVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348

    PubMed  CAS  Google Scholar 

  • Withers HR, Taylor JM, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

    Article  PubMed  CAS  Google Scholar 

  • Wolfson AH, Abdel-Wahab M, Markoe AM et al (1997) A quantitative assessment of standard versus customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 37:237–242

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mutyala, S., Wolfson, A.H. (2008). Cervical Cancer. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-77385-6_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-77384-9

  • Online ISBN: 978-3-540-77385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics